Systematic review of 19 studies (9 meta-analysed; 1075 patients) in adults with CRSwNP: switching dupilumab from every 2 to every 4 weeks showed no significant change in SNOT-22, congestion, smell, polyp or Lund-Mackay scores; eosinophils fell slightly.
Meta-analysisn = 1,075
Alqutub et al. Dupilumab Extended Interval Dosing in Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review and Meta-analysis